Treatment of Clostridium difficile Infection in an Initial Episode With No Prior CDI
Clinical Scenario
This protocol addresses patients presenting with their first episode of
Clostridioides difficile infection and no history of prior CDI.
Management at this stage is shaped by disease severity and the availability
of preferred agents.
Treatment Approach
Oral antibiotic therapy is used, with agent selection guided by disease
severity. A preferred first-choice agent is distinguished from alternatives —
the full regimen with selection criteria and sequencing is available in the
structured protocol below.
Clinical Targets
- Initial clinical cure: no diarrhea for 2 consecutive days, assessed at end of therapy
- Sustained response: confirmed resolution of CDI at 4 weeks after end of therapy
References
DOI: 10.1093/cid/ciab549
- For patients with an initial CDI episode, we suggest using fidaxomicin rather than a standard course of vancomycin (conditional recommendation, moderate certainty of evidence).
- Preferred: Fidaxomicin 200 mg given twice daily for 10 days
- Alternative: Vancomycin 125 mg given 4 times daily by mouth for 10 days
- Alternative for nonsevere CDI, if above agents are unavailable: Metronidazole, 500 mg 3 times daily by mouth for 10–14 days
- Definition of nonsevere CDI is supported by the following laboratory parameters: White blood cell count of 15 000 cells/µL or lower and a serum creatinine level <1.5 mg/dL
View source ↗